Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology

MCK Leung, PL Williams, A Benedetto… - Toxicological …, 2008 - academic.oup.com
The nematode Caenorhabditis elegans has emerged as an important animal model in
various fields including neurobiology, developmental biology, and genetics. Characteristics …

α-Synuclein: membrane interactions and toxicity in Parkinson's disease

PK Auluck, G Caraveo… - Annual review of cell and …, 2010 - annualreviews.org
In the late 1990s, mutations in the synaptic protein α-synuclein (α-syn) were identified in
families with hereditary Parkinson's disease (PD). Rapidly, α-syn became the target of …

Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases

AG Alexander, V Marfil, C Li - Frontiers in genetics, 2014 - frontiersin.org
Advances in research and technology has increased our quality of life, allowed us to combat
diseases, and achieve increased longevity. Unfortunately, increased longevity is …

Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation

AT Van Der Goot, W Zhu… - Proceedings of the …, 2012 - pnas.org
Toxicity of aggregation-prone proteins is thought to play an important role in aging and age-
related neurological diseases like Parkinson and Alzheimer's diseases. Here, we identify …

Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease

Z Zhang, G Li, SSW Szeto, CM Chong, Q Quan… - Free Radical Biology …, 2015 - Elsevier
Polypharmacology-based strategies using drug combinations with different mechanisms of
action are gaining increasing attention as a novel methodology to discover potentially …

Genetics and epigenetics of Parkinson′ s disease

F Coppedè - The Scientific World Journal, 2012 - Wiley Online Library
In 1997 a mutation in the a-synuclein (SNCA) gene was associated with familial autosomal
dominant Parkinson's disease (PD). Since then, several loci (PARK1‐15) and genes have …

Modeling neurodegenerative diseases in Caenorhabditis elegans

J Li, W Le - Experimental neurology, 2013 - Elsevier
Neurodegenerative diseases which include Alzheimer's disease (AD), Parkinson's disease
(PD), amyotrophic lateral sclerosis (ALS), Huntington disease (HD), and others are …

[HTML][HTML] Neurodegeneration and epigenetics: A review

P Ghosh, A Saadat - Neurología (English Edition), 2023 - Elsevier
Neuronal function and differentiation are tightly regulated by both genome and epigenome.
Based on the environmental information the epigenetic changes occur. Neurodegeneration …

Epigenetics in Parkinson's disease

MAS Pavlou, TF Outeiro - Neuroepigenomics in aging and disease, 2017 - Springer
Parkinson's disease (PD) is a highly complex neurodegenerative disorder with a
multifactorial origin. Although several cellular mechanisms and genes have been implicated …

The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models

AL Knight, X Yan, S Hamamichi, RR Ajjuri, JR Mazzulli… - Cell metabolism, 2014 - cell.com
Neurodegenerative diseases represent an increasing burden in our aging society, yet the
underlying metabolic factors influencing onset and progression remain poorly defined. The …